Literature DB >> 11685035

Critical assessment of the outcome of infrainguinal vein bypass.

J Golledge1, J Iannos, J A Walsh, J R Burnett, R K Foreman.   

Abstract

OBJECTIVE: To perform a more critical assessment of infrainguinal vein bypass. SUMMARY BACKGROUND DATA: Graft patency may give an unrealistic impression of the outcome of bypass surgery.
METHODS: During a 6-year period, 236 patients undergoing primary vein grafts were entered into the study. An ideal outcome required the patient to have survived 12 months with a patent graft on duplex scanning, no perioperative complication, and no further related open or endovascular surgery or admission.
RESULTS: At 12 months, the secondary graft patency rate was 82%; however, only 22% of patients had an ideal outcome. At 1 year, 44 (19%) patients died, 93 (39%) required further ipsilateral and 39 (17%) contralateral intervention, and a total of 108 (46%) were readmitted. An ideal outcome was more likely in patients receiving calcium channel blockers, principally because of improved primary patency, and less likely in those with cardiac failure requiring furosemide, principally because of worse survival in these patients.
CONCLUSIONS: Few patients achieve an ideal result after infrainguinal vein bypass. Outcome may be improved by the use of calcium channel blockers. Careful consideration is required before performing revascularization in patients with cardiac failure.

Entities:  

Mesh:

Year:  2001        PMID: 11685035      PMCID: PMC1422096          DOI: 10.1097/00000658-200111000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

Review 1.  Adjuvant medical therapy in peripheral bypass surgery.

Authors:  H R Watson; G Belcher; M Horrocks
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

2.  Patient-assessed health outcomes in peripheral arterial disease.

Authors:  J Golledge; A Garratt; R M Greenhalgh; A H Davies
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-02       Impact factor: 7.069

3.  Does a completely accomplished duplex-based surveillance prevent vein-graft failure?

Authors:  L Ihlberg; M Luther; A Albäck; I Kantonen; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-11       Impact factor: 7.069

4.  Patency and characteristics of lower extremity vein grafts requiring multiple revisions.

Authors:  G J Landry; G L Moneta; L M Taylor; J M Edwards; R A Yeager; J M Porter
Journal:  J Vasc Surg       Date:  2000-07       Impact factor: 4.268

Review 5.  Lower-limb arterial disease.

Authors:  J Golledge
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

6.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

7.  Intensive surveillance of femoropopliteal-tibial autogenous vein bypasses improves long-term graft patency and limb salvage.

Authors:  T M Bergamini; S M George; H T Massey; P K Henke; T W Klamer; G E Lambert; F B Miller; R N Garrison; J D Richardson
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

8.  Arterial flow conditions downregulate thrombomodulin on saphenous vein endothelium.

Authors:  M Gosling; J Golledge; R J Turner; J T Powell
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

9.  Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

Authors:  E Hoberg; R Dietz; U Frees; H A Katus; B Rauch; A Schömig; G Schuler; F Schwarz; H Tillmanns; J Niebauer
Journal:  Br Heart J       Date:  1994-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.